Invivyd Inc
NASDAQ:IVVD
| Market Cap (Intraday) | 186.43M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | 5.39 |
| 10-Day MA | $0.81 |
| 50-Day MA | $0.74 |
| 200-Day MA | $0.76 |
Invivyd Inc Stock, NASDAQ:IVVD
1601 Trapelo Road, Suite 178, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.819.0080
Number of Employees: 99
Description
Invivyd, Inc. engages in the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The firm develops antibodies that can neutralize SARS-CoV-2, SARS-CoV-1, and additional emergent coronaviruses. It offers, ADG20, a monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses. The company was founded by Tillman U. Gerngross, Ren Russo and Laura Walker on June 3, 2020 and is headquartered in Waltham, MA.